The expression levels of PD-1 and PD-L1 were higher in the low-TIIC score group than in the high-TIIC score group in both the tumor and the stroma, which may account for the responsiveness of the low-TIIC score group to immunotherapy. The gene discussed is CD274; the disease is neoplasm.